Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/INF.0b013e31820b583d | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!